285 related articles for article (PubMed ID: 3012199)
21. Morphologic characteristics of the parathyroid and thyroid glands and serum immunoreactive parathyroid hormone in dogs with pseudohyperparathyroidism.
Yarrington JT; Hoffman WE; Macy D; Hawker C
Am J Vet Res; 1981 Feb; 42(2):271-4. PubMed ID: 6894831
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
23. Effects of gallium nitrate in nude mice bearing a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Merryman JI; Capen CC; Rosol TJ
J Bone Miner Res; 1994 May; 9(5):725-32. PubMed ID: 8053402
[TBL] [Abstract][Full Text] [Related]
24. Association of hypercalcemia with tumors producing colony-stimulating factor(s).
Kondo Y; Sato K; Ohkawa H; Ueyama Y; Okabe T; Sato N; Asano S; Mori M; Ohsawa N; Kosaka K
Cancer Res; 1983 May; 43(5):2368-74. PubMed ID: 6600966
[TBL] [Abstract][Full Text] [Related]
25. Hypercalcemia and neoplasia. Biologic, biochemical, and ultrastructural studies of a hypercalcemia-producing Leydig cell tumor of the rat.
Rice BF; Roth LM; Cole FE; MacPhee AA; Davis K; Ponthier RL; Sternberg WH
Lab Invest; 1975 Oct; 33(4):428-39. PubMed ID: 52757
[TBL] [Abstract][Full Text] [Related]
26. Morphological changes in the parathyroid gland of rats with humoral hypercalcaemia of malignancy.
Nakanishi M; Sawamoto O; Kawashima M; Kuwamura M; Yamate J
J Comp Pathol; 2004 Jul; 131(1):92-7. PubMed ID: 15144804
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
28. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors.
Kukreja SC; Shevrin DH; Wimbiscus SA; Ebeling PR; Danks JA; Rodda CP; Wood WI; Martin TJ
J Clin Invest; 1988 Nov; 82(5):1798-802. PubMed ID: 2846659
[TBL] [Abstract][Full Text] [Related]
30. Increased renal calcium reabsorption in an animal model of hypercalcemia of human malignancy.
Shipley PJ; Shevrin DH; Kukreja SC
J Bone Miner Res; 1988 Oct; 3(5):555-60. PubMed ID: 3195367
[TBL] [Abstract][Full Text] [Related]
31. Morphologic and functional studies of a rat hypercalcemia-associated testicular tumor maintained in cell culture.
Saxe AW; Santora A; Norton J; Triche T; Brennan MF; Spiegel A
Surgery; 1985 Dec; 98(6):1013-23. PubMed ID: 3000012
[TBL] [Abstract][Full Text] [Related]
32. Bone changes in hypercalcemia of malignancy in dogs.
Norrdin RW; Powers BE
J Am Vet Med Assoc; 1983 Aug; 183(4):441-4. PubMed ID: 6688616
[TBL] [Abstract][Full Text] [Related]
33. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
[TBL] [Abstract][Full Text] [Related]
34. Humoral hypercalcemia caused by a rat Leydig-cell tumor is associated with suppressed parathyroid hormone secretion and increased urinary cAMP excretion.
Spiegel AM; Saxe AW; Deftos LJ; Brennan MF
Horm Metab Res; 1983 Jun; 15(6):299-304. PubMed ID: 6307850
[TBL] [Abstract][Full Text] [Related]
35. Quantitative bone histomorphometry in nude mice bearing a human squamous cell lung cancer.
Kukreja SC; Rosol TJ; Shevrin DH; York PA
J Bone Miner Res; 1988 Jun; 3(3):341-6. PubMed ID: 3213626
[TBL] [Abstract][Full Text] [Related]
36. [Esophageal carcinoma with hypercalcemia that appeared to be caused by prostaglandin E2 produced by the tumor cells].
Maeda Y; Sasaki T; Mochizuki M; Koike M
Gan No Rinsho; 1990 Nov; 36(14):2445-9. PubMed ID: 2250367
[TBL] [Abstract][Full Text] [Related]
37. Establishment of nude mouse transplantable model of a human adenoid cystic carcinoma of the oral floor showing metastasis to the lymph node and lung.
Hashitani S; Urade M; Zushi Y; Segawa E; Okui S; Sakurai K
Oncol Rep; 2007 Jan; 17(1):67-72. PubMed ID: 17143480
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo.
Sato K; Fujii Y; Kasono K; Ozawa M; Imamura H; Kanaji Y; Kurosawa H; Tsushima T; Shizume K
Endocrinology; 1989 May; 124(5):2172-8. PubMed ID: 2539970
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of in vitro bone resorption by a parathyroid hormone receptor antagonist in the canine adenocarcinoma model of humoral hypercalcemia of malignancy.
Rosol TJ; Capen CC
Endocrinology; 1988 May; 122(5):2098-102. PubMed ID: 2834184
[TBL] [Abstract][Full Text] [Related]
40. Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy.
Insogna KL; Stewart AF; Vignery AM; Weir EC; Namnum PA; Baron RE; Kirkwood JM; Deftos LM; Broadus AE
Endocrinology; 1984 Mar; 114(3):888-96. PubMed ID: 6546543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
